MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Bioventus EBITDA per Share 2011-2026 | BVS
Annual EBITDA per Share Bioventus
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.39 | -1.82 | 1.03 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.03 | -1.82 | -0.393 |
Quarterly EBITDA per Share Bioventus
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.19 | 0.3 | 0.25 | 0.09 | -0.46 | 0.26 | 0.08 | 0.14 | -1.22 | - | -2.02 | -0.01 | -0.15 | - | 0.53 | 0.21 | 0.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.7 | -2.02 | -0.074 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.96 | 4.59 % | $ 96.1 K |  USA |
 |
Agilent Technologies
A
|
5.49 | $ 120.72 | 1.45 % | $ 36.7 B | USA |
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-0.28 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 22.3 | -5.27 % | $ 234 M |  China |
 |
Celcuity
CELC
|
-2.87 | $ 111.84 | 4.13 % | $ 4.41 B | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 28.19 | 2.25 % | $ 783 M | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 14.04 | 1.81 % | $ 424 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 180.3 | 2.54 % | $ 8.94 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
IDEXX Laboratories
IDXX
|
18.7 | $ 649.32 | 2.17 % | $ 52.2 B | USA |
 |
Illumina
ILMN
|
-3.01 | $ 129.66 | 0.07 % | $ 20.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 281.13 | -0.68 % | $ 23.4 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 77.83 | -1.27 % | $ 5.25 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
-0.22 | $ 15.04 | -2.97 % | $ 1.95 B | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 294.19 | -1.66 % | $ 26.7 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 5.34 | 0.85 % | $ 494 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 9.16 | -3.93 % | $ 1.17 B | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
1.64 | $ 13.23 | -1.19 % | $ 325 M | USA |
 |
BioNano Genomics
BNGO
|
-70.8 | $ 1.16 | 3.12 % | $ 1.47 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 208.81 | 0.22 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 204.82 | 0.38 % | $ 146 B | USA |
 |
Organovo Holdings
ONVO
|
-8.44 | - | -2.3 % | $ 19.4 M | USA |
 |
OPKO Health
OPK
|
-0.08 | $ 1.2 | 0.84 % | $ 833 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | $ 103.52 | 0.14 % | $ 19.5 B | USA |
 |
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.59 | 4.28 % | $ 477 M | USA |
 |
DarioHealth Corp.
DRIO
|
-1.96 | $ 10.0 | -2.91 % | $ 284 M | Israel |
 |
DexCom
DXCM
|
2.98 | $ 73.02 | -0.08 % | $ 28.5 B | USA |
 |
PerkinElmer
PKI
|
6.54 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
-0.21 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-4.93 | $ 26.96 | 7.95 % | $ 35 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.35 | - | - | $ 10.6 B |  Niderland |
 |
Personalis
PSNL
|
-0.97 | $ 8.86 | 2.13 % | $ 525 M | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 110.12 | 1.31 % | $ 9.08 B |  Irlanda |
 |
Quotient Limited
QTNT
|
-0.806 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Renalytix AI plc
RNLX
|
-0.27 | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 19.23 | 2.29 % | $ 1.02 B | USA |